Literature DB >> 21161441

Making the case for private cord blood banking: mission accomplished!: comment to Schmidt et al., Stem Cell Rev and Rep (2010) 6:234-236.

Peter Hollands1, Karl-Heinz Preisegger.   

Abstract

Mesh:

Year:  2011        PMID: 21161441     DOI: 10.1007/s12015-010-9223-5

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


× No keyword cloud information.
  14 in total

Review 1.  Tissue regeneration potential in human umbilical cord blood.

Authors:  Hadar Arien-Zakay; Philip Lazarovici; Arnon Nagler
Journal:  Best Pract Res Clin Haematol       Date:  2010-06       Impact factor: 3.020

Review 2.  Adult stem cells for cardiac tissue engineering.

Authors:  Eliana C Martinez; Theo Kofidis
Journal:  J Mol Cell Cardiol       Date:  2010-08-13       Impact factor: 5.000

Review 3.  Adult cell therapy for brain neuronal damages and the role of tissue engineering.

Authors:  Gaëtan J-R Delcroix; Paul C Schiller; Jean-Pierre Benoit; Claudia N Montero-Menei
Journal:  Biomaterials       Date:  2009-12-14       Impact factor: 12.479

Review 4.  Private cord blood banking: current use and clinical future.

Authors:  Peter Hollands; Catherina McCauley
Journal:  Stem Cell Rev Rep       Date:  2009-07-15       Impact factor: 5.739

5.  Umbilical cord blood stem cells for myocardial repair and regeneration.

Authors:  Nicholas Greco; Mary J Laughlin
Journal:  Methods Mol Biol       Date:  2010

6.  The Ink4/Arf locus is a barrier for iPS cell reprogramming.

Authors:  Han Li; Manuel Collado; Aranzazu Villasante; Katerina Strati; Sagrario Ortega; Marta Cañamero; Maria A Blasco; Manuel Serrano
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

7.  Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group.

Authors:  E Gluckman; V Rocha; A Boyer-Chammard; F Locatelli; W Arcese; R Pasquini; J Ortega; G Souillet; E Ferreira; J P Laporte; M Fernandez; C Chastang
Journal:  N Engl J Med       Date:  1997-08-07       Impact factor: 91.245

8.  Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging.

Authors:  Ander Matheu; Cristina Pantoja; Alejo Efeyan; Luis M Criado; Juan Martín-Caballero; Juana M Flores; Peter Klatt; Manuel Serrano
Journal:  Genes Dev       Date:  2004-11-01       Impact factor: 11.361

9.  Hematopoietic and immune recovery after transplantation of cord blood progenitor cells in children.

Authors:  F Locatelli; R Maccario; P Comoli; F Bertolini; G Giorgiani; D Montagna; F Bonetti; P De Stefano; G Rondini; G Sirchia; F Severi
Journal:  Bone Marrow Transplant       Date:  1996-12       Impact factor: 5.483

10.  Senescence impairs successful reprogramming to pluripotent stem cells.

Authors:  Ana Banito; Sheikh T Rashid; Juan Carlos Acosta; SiDe Li; Carlos F Pereira; Imbisaat Geti; Sandra Pinho; Jose C Silva; Veronique Azuara; Martin Walsh; Ludovic Vallier; Jesús Gil
Journal:  Genes Dev       Date:  2009-08-20       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.